Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.

about

Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia

P2860

Q36192755-1A328F6A-A23B-4E0D-A29D-8A589FEA3ED4

P2860

Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.

Item

http://www.wikidata.org/entity/Q53811523

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pediatric extended spectrum β- ...... fection and treatment options.

@en

Pediatric extended spectrum β- ...... fection and treatment options.

@nl

type

Item

label

Pediatric extended spectrum β- ...... fection and treatment options.

@en

Pediatric extended spectrum β- ...... fection and treatment options.

@nl

prefLabel

Pediatric extended spectrum β- ...... fection and treatment options.

@en

Pediatric extended spectrum β- ...... fection and treatment options.

@nl

P1476

Pediatric extended spectrum β- ...... fection and treatment options.

@en

P2093

Chonnamet Techasaensiri

http://www.w3.org/2001/XMLSchema#string

Napapailin Sethaphanich

http://www.w3.org/2001/XMLSchema#string

Nopporn Apiwattanakul

http://www.w3.org/2001/XMLSchema#string

Pitak Santanirand

http://www.w3.org/2001/XMLSchema#string

Sasivimol Rattanasiri

http://www.w3.org/2001/XMLSchema#string

Sujittra Chaisavaneeyakorn

http://www.w3.org/2001/XMLSchema#string

P2860

The CTX-M beta-lactamase pandemic.

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.

Extended-spectrum beta-lactamases and clinical outcomes: current data.

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes

Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.

Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.

Properties of plasmids responsible for production of extended-spectrum beta-lactamases

P304

338-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PED.12845

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26513341

http://www.w3.org/2001/XMLSchema#string

Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.

about

P2860

P2860

Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698